tiprankstipranks
Trending News
More News >
Climb Bio (CLYM)
NASDAQ:CLYM
US Market

Climb Bio (CLYM) Financial Statements

Compare
660 Followers

Climb Bio Financial Overview

Climb Bio's market cap is currently $270.01M. The company's EPS TTM is $-0.19; its P/E ratio is -5.27; Climb Bio is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.19. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -82.02M$ -40.27M$ -45.13M$ -35.67M$ -20.93M
EBITDA$ -30.36M$ -40.27M$ -45.13M$ -35.67M$ -11.77M
Net Income$ -73.90M$ -35.12M$ -45.24M$ -47.48M$ -20.67M
Balance Sheet
Cash & Short-Term Investments$ 150.92M$ 106.80M$ 123.57M$ 136.48M$ 20.49M
Total Assets$ 217.19M$ 110.47M$ 134.99M$ 173.24M$ 24.63M
Total Debt$ 532.00K$ 349.00K$ 480.00K$ 0.00$ 0.00
Net Debt$ -86.70M$ -92.76M$ -43.10M$ -46.92M$ -20.49M
Total Liabilities$ 5.31M$ 2.87M$ 6.28M$ 6.04M$ 3.06M
Stockholders' Equity$ 211.88M$ 107.60M$ 128.72M$ 167.20M$ 21.57M
Cash Flow
Free Cash Flow$ -15.56M$ -20.60M$ -37.37M$ -36.07M$ -14.10M
Operating Cash Flow$ -15.56M$ -20.60M$ -37.37M$ -36.07M$ -14.10M
Investing Cash Flow$ -121.09M$ 68.98M$ 34.44M$ -114.97M$ 8.08M
Financing Cash Flow$ 130.73M$ 841.00K$ 0.00$ 177.23M$ 4.92M
Currency in USD

Climb Bio Earnings and Revenue History

Climb Bio Debt to Assets

Climb Bio Cash Flow

Climb Bio Forecast EPS vs Actual EPS